FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

The Food and Drug Administration (FDA) authorized Novavax’s COVID vaccine for adults on Wednesday, offering a protein-based alternative to mRNA shots from other pharmaceutical companies.

The newly authorized vaccine is scheduled in two doses separated by 21 days.

 

FDA Authorizes Novavax COVID Vaccine

Historic Heatwave To Hit Northwest, Along With A Plague Of “Voracious Grasshoppers”

Meteorologists are warning of the worst heatwave that the…

Pennsylvania Lifts COVID-19 Mask Order After More Than a Year

As of 12:01 a.m. on Monday, June 28, Pennsylvania's long-standing…

U.S. Army Won’t Punish Chaplain for Criticizing Biden Transgender Policy

U.S. Army chaplain Major Andrew Calvert received a formal…